Ullet index:DAIICHI SANKYO COMPANY, LIMITED:4568

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index DAIICHI SANKYO COMPANY, LIMITED Go to web site 4568 Medicals 東証プライム March 1, 2000 2005.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

DAIICHI SANKYO COMPANY, LIMITED mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 1,445,854
plusup
1,350,872
plusup
1,272,053
plusdown
1,305,810
plusup
1,249,643
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 109,188
plusup
66,973
plusdown
75,956
plusdown
129,075
plusup
93,410
plus
Operating Cash Flow(OFC)Help 114,514
plusdown
139,226
plusdown
192,207
plusdown
196,601
plusup
92,033
plus
Free Cash Flow(FCF)Help -143,268
plusdown
351,565
plusup
152,961
plusdown
278,274
plusup
-50,487
plus
OFC - Net IncomeHelp 72
plusup
66
plusup
65
plusdown
65
plusup
61
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp 21.46%
plusdown
22.54%
plusdown
31.06%
plusup
25.60%
plusup
11.86%
plus
Current Assets / Amount of SalesHelp 41.75%
plusdown
59.13%
plusdown
64.28%
plusdown
78.24%
plusdown
83.50%
plus
Free Cash Revenue RatioHelp -11.21%
plusdown
33.65%
plusup
15.89%
plusdown
28.34%
plusup
-5.43%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

DAIICHI SANKYO COMPANY, LIMITED

Company where related level is highHelp

Perseus Proteomics Inc.
Otsuka Holdings Co.,Ltd.
TMS Co.,Ltd.
ONO PHARMACEUTICAL CO.,LTD.
Renascience Inc.
JCR Pharmaceuticals Co.,Ltd.
D.Western Therapeutics Institute, Inc.
AnGes,Inc.
StemRIM Inc.
ASKA Pharmaceutical Holdings Co., Ltd.